Veradermics, Inc cotiza a 116.26 USD y tiene una capitalización bursátil de $4.9B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men …
| Periodo | 2026-11 | 2026-08 | 2026-03 |
|---|---|---|---|
| Real | — | — | $-104.54 |
| Estimado | $-0.64 | $-0.64 | $-18.24 |
| Sorpresa | — | — | -473.1% |
| Métrica | MANE | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -45.9% | -32.0% | -13.9% |
| Current Ratio | 16.66 | 2.84 | +13.82 |
| Debt / Equity | — | 0.28 | — |